WHO cautions against use of remdesivir for hospitalised COVID-19 patients
It is authorised or approved for use as a COVID-19 treatment in more than 50 countries
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
SOLIDARITY Trial
Disappointing SOLIDARITY results for remdesivir likely due to trial differences and not the drug:…
The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing…
HCQ in COVID-19: Repurposing with a purpose in the background of a ‘lost cause’
Dr Dhananjay Bakhle shares a rebuttal to an article, Explained: What works (and does not) in Covid treatment', written by Dr…